Peer Review reports
From: MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway
Original Submission | ||
---|---|---|
16 Feb 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
27 Mar 2022 | Reviewed | Reviewer Report - Srinivas Chatla |
6 Apr 2022 | Reviewed | Reviewer Report |
16 Apr 2022 | Author responded | Author comments - Minghua Yu |
Resubmission - Version 3 | ||
16 Apr 2022 | Submitted | Manuscript version 3 |
21 Apr 2022 | Author responded | Author comments - Minghua Yu |
Resubmission - Version 4 | ||
21 Apr 2022 | Submitted | Manuscript version 4 |
27 Apr 2022 | Author responded | Author comments - Minghua Yu |
Resubmission - Version 5 | ||
27 Apr 2022 | Submitted | Manuscript version 5 |
5 May 2022 | Reviewed | Reviewer Report - Srinivas Chatla |
12 May 2022 | Reviewed | Reviewer Report |
20 May 2022 | Author responded | Author comments - Minghua Yu |
Resubmission - Version 6 | ||
20 May 2022 | Submitted | Manuscript version 6 |
Publishing | ||
27 May 2022 | Editorially accepted | |
2 Jun 2022 | Article published | 10.1186/s12885-022-09709-8 |
You can find further information about peer review here.